Macular Edema: all 847 studies
Page 3 of 9. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)CompletedNCT01396083Phase 3Results posted
- Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01396057Phase 3Results posted
- Topical Interferon Gamma for Macular Edema Secondary to UveitisCompletedNCT01376362Phase 1/2Results posted
- Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular EdemaCompletedNCT01363440Phase 3Results posted
- Intravitreal Aflibercept Injection in Vision Impairment Due to DMECompletedNCT01331681Phase 3Results posted
- NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)CompletedNCT01331005Phase 2Results posted
- Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal MethotrexateTerminatedNCT01314417Phase 1/2Results posted
- Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension StudyCompletedNCT01304706Phase 3Results posted
- Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to BevacizumabCompletedNCT01292798Phase 1/2Results posted
- A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein OcclusionCompletedNCT01277302Phase 4Results posted
- REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab StudyCompletedNCT01247220Phase 2Results posted
- Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)CompletedNCT01231633Not applicableResults posted
- Extended Follow-up of Patients With Macular Edema Due to Retinal Vein OcclusionCompletedNCT01198327Phase 3Results posted
- Microplasmin Intravitreal Administration in Participants With Uveitic Macular EdemaTerminatedNCT01194674Phase 1/2Results posted
- Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular EdemaCompletedNCT01189461Phase 3Results posted
- Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes MellitusCompletedNCT01171976Phase 3Results posted
- Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)CompletedNCT01135914Phase 3Results posted
- Safety and Efficacy of Ranibizumab in Diabetic Macular EdemaTerminatedNCT01131585Phase 3Results posted
- A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular EdemaCompletedNCT01120899Phase 1/2Results posted
- A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular EdemaCompletedNCT01100307Phase 3Results posted
- Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein OcclusionCompletedNCT01085734Phase 4Results posted
- Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 StudyCompletedNCT01077401Phase 2Results posted
- Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular EdemaTerminatedNCT01042678Phase 1Results posted
- Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)CompletedNCT01027650Phase 1/2Results posted
- Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)CompletedNCT01012973Phase 3Results posted
- Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular EdemaCompletedNCT00989989Phase 3Results posted
- Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)CompletedNCT00943072Phase 3Results posted
- Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular EdemaCompletedNCT00901186Phase 2Results posted
- Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular EdemaCompletedNCT00826618Phase 1Results posted
- Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral NonperfusionCompletedNCT00815360Phase 2Results posted
- Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular EdemaCompletedNCT00799227Phase 2Results posted
- Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular EdemaCompletedNCT00790803Not applicableResults posted
- DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical ImpactCompletedNCT00789477Phase 2Results posted
- A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy PatientsCompletedNCT00782717Phase 2Results posted
- Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional TherapiesTerminatedNCT00779142Not applicableResults posted
- Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in RetinaTerminatedNCT00770770Phase 2Results posted
- Efficacy of Aliskiren in the Treatment of Diabetic Macular EdemaTerminatedNCT00768040Phase 2Results posted
- Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)CompletedNCT00729846Phase 2Results posted
- Treatment of Cystoid Macular Edema in Patients With Retinal DegenerationCompletedNCT00716586Phase 4Results posted
- Sirolimus to Treat Diabetic Macular EdemaCompletedNCT00711490Phase 1/2Results posted
- Evaluation of Vitrectomy for Diabetic Macular EdemaCompletedNCT00709319Results posted
- A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension StudyCompletedNCT00687804Phase 3Results posted
- Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular EdemaCompletedNCT00682539Phase 4Results posted
- Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)TerminatedNCT00668785Phase 2Results posted
- A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.CompletedNCT00605280Phase 2/3Results posted
- Lucentis for Inflammatory Macular Edema TrialCompletedNCT00498355Phase 1/2Results posted
- Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract SurgeryCompletedNCT00494494Phase 4Results posted
- Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular EdemaCompletedNCT00490815Phase 3Results posted
- A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)CompletedNCT00486018Phase 3Results posted
- A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)CompletedNCT00485836Phase 3Results posted
- Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory MedicationsCompletedNCT00476593Not applicableResults posted
- A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)CompletedNCT00473382Phase 3Results posted
- A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)CompletedNCT00473330Phase 3Results posted
- Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular EdemaCompletedNCT00464685Phase 2Results posted
- Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic RetinopathyCompletedNCT00445003Phase 3Results posted
- Laser-Ranibizumab-Triamcinolone for Diabetic Macular EdemaCompletedNCT00444600Phase 3Results posted
- The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) StudyCompletedNCT00407381Phase 2Results posted
- Ranibizumab (Lucentis) for Macular Edema Secondary to Vein OcclusionsCompletedNCT00407355Phase 1/2Results posted
- Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein OcclusionCompletedNCT00406107Phase 4Results posted
- An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVOCompletedNCT00379795Not applicableResults posted
- A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular EdemaCompletedNCT00369486Phase 2Results posted
- Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular EdemaCompletedNCT00367133Phase 3Results posted
- Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular EdemaCompletedNCT00344968Phase 3Results posted
- A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)CompletedNCT00336323Phase 2Results posted
- Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center InvolvementCompletedNCT00284050Phase 2Results posted
- Efalizumab to Treat UveitisCompletedNCT00280826Phase 1Results posted
- Triamcinolone vs. Laser for Diabetic Macular EdemaCompletedNCT00229931Not applicableResults posted
- A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaCompletedNCT00168389Phase 3Results posted
- A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaCompletedNCT00168337Phase 3Results posted
- A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionCompletedNCT00168324Phase 3Results posted
- A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionCompletedNCT00168298Phase 3Results posted
- Effect of Ruboxistaurin on Clinically Significant Macular EdemaCompletedNCT00133952Phase 3Results posted
- The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) StudyCompletedNCT00105027Phase 3Results posted
- Reduction in the Occurrence of Center-Involved Diabetic Macular EdemaCompletedNCT00090519Phase 3Results posted
- Comparison Between Low-Dose and High-Dose Nepafenac SodiumCompletedNCT07749027Not applicable
- Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour PeriodCompletedNCT07090044Phase 4
- Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic PatientsCompletedNCT06882551Phase 4
- Change in Ocular Perfusion After Intravitreal Anti-VEGF in Patients with Age-related Maculopathy or Diabetic Macula EdemaCompletedNCT06878573
- Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.Active, not recruitingNCT06846073Not applicable
- Ocular Safety and Usability Study for FYB203 PFSCompletedNCT06708637Phase 4
- Ocular Safety and Usability Study for FYB201 PFSCompletedNCT06708624Phase 4
- Incidence of Macular Edema in a Uveitis PopulationActive, not recruitingNCT06686641
- The Use of ARA290 for the Treatment of Diabetic Macular OedemaTerminatedNCT06626971Phase 2
- Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular EdemaActive, not recruitingNCT06498050Phase 4
- Effectiveness Of Suprachoroidal Injection In Diabetic Macular EdemaActive, not recruitingNCT06449768
- The Role of Radial Peripapillary Vessel Density in Irvine-gass SyndromeCompletedNCT06436170
- Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein OcclusionCompletedNCT06416241Phase 4
- An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World SettingWithdrawnNCT06398080
- A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular EdemaCompletedNCT06305416Phase 3
- Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic RetinopathyActive, not recruitingNCT06305143Phase 4
- Manage Macular Cystoid Edema With Retinal Vein Obstruction Using Traditional Chinese Medicine and RanibizumabCompletedNCT06234514Phase 4
- Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus ImagesCompletedNCT06213896
- Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular EdemaCompletedNCT06179030
- Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)CompletedNCT06099184Phase 2
- Evaluation of IBI302 Injection in nAMD or DMESuspendedNCT05961007Phase 1/2
- Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.CompletedNCT05959304Phase 4
- Comparative Study Between IVI of Ranibizumab with and Without Prior ACP in Patients with DME Using OCT-ACompletedNCT05861466Phase 4
- Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema:CompletedNCT05847088
- Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial Intensive Treatment in the Real World Clinical Setting in Korea (Rising K)CompletedNCT05815212
- Vitreous Hyper Reflective Dots in Association With Pseudophakic Cystoid Macular EdemaCompletedNCT05811182